Page last updated: 2024-08-18

pyrroles and Gastric Diseases

pyrroles has been researched along with Gastric Diseases in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akasaka, T; Ishida, H; Kato, S; Kawamoto, Y; Mori, K1
Inatomi, N; Matsukawa, J; Otake, K1
Bertaccini, G; Coruzzi, G1
Dominick, MA; McGuire, EJ; Sigler, RE1
Erwin, WD; Gullikson, GW; Loeffler, R; Virina, MA1

Reviews

1 review(s) available for pyrroles and Gastric Diseases

ArticleYear
[Pharmacological and clinical profiles of a novel potassium-competitive acid blocker, vonoprazan fumarate (Takecab(®) 10 mg and 20 mg)].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2015, Volume: 146, Issue:5

    Topics: Animals; Clinical Trials as Topic; Gastric Acid; Humans; Potassium; Potassium Channel Blockers; Pyrroles; Stomach Diseases; Sulfonamides

2015

Other Studies

4 other study(ies) available for pyrroles and Gastric Diseases

ArticleYear
Gastric candidiasis developing after administration of potassium-competitive acid blocker.
    Gastrointestinal endoscopy, 2019, Volume: 90, Issue:5

    Topics: Candidiasis; Humans; Male; Middle Aged; Pyrroles; Stomach Diseases; Sulfonamides

2019
Gastric effects of the novel non-steroidal anti-inflammatory drug amtolmetin guacyl.
    Nutrition (Burbank, Los Angeles County, Calif.), 1999, Volume: 15, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Glycine; Humans; Nitric Oxide; Pyrroles; Stomach Diseases

1999
Subacute toxicity of a halogenated pyrrole hydroxymethylglutaryl-coenzyme A reductase inhibitor in Wistar rats.
    Toxicologic pathology, 1992, Volume: 20, Issue:4

    Topics: Animals; Body Weight; Dose-Response Relationship, Drug; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Keratosis; Liver; Male; Mevalonic Acid; Necrosis; Neoplasms, Experimental; Organ Size; Pyrroles; Rats; Rats, Wistar; Stomach; Stomach Diseases

1992
Alpha 2-adrenergic model of gastroparesis: validation with renzapride, a stimulator of motility.
    The American journal of physiology, 1991, Volume: 261, Issue:3 Pt 1

    Topics: Adrenergic alpha-Agonists; Animals; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cresols; Disease Models, Animal; Dogs; Duodenum; Eating; Gastric Emptying; Gastrointestinal Motility; Muscle, Smooth; Paralysis; Pyrroles; Receptors, Adrenergic, alpha; Serotonin Antagonists; Stomach Diseases; Technetium Tc 99m Sulfur Colloid

1991